{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.4767.4767",
    "article_title": "Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol ",
    "article_date": "December 7, 2017",
    "session_type": "112. Thalassemia and Globin Gene Regulation",
    "abstract_text": "Gadolinium based contrast agents (GBCA) are used in magnetic resonance imaging (MRI) in order to improve the detection and the characterization of pathophysiologic processes. Many studies have reported an association between increased signal intensities (SI) on unenhanced T1-weighted MRI images in different brain regions and the history of repeated intravenous administrations of GBCAs in patients with normal renal function. We conducted a prospective study aimed to evaluate signal changes in the dentate nucleus (DN), globus pallidus (GP), pons, and thalamus (normalized to the deep cerebellum white matter) in T1-MRI images after serial injections of Gadobutrol for the study of the heart in patients with thalassemia. Among the thalassemic patients who underwent a brain MRI within a pilot study for iron overload assessment, we selected two groups of patients: 15 patients transfused and chelated with\u22654 Gadobutrol administrations at a high dose (0.2 mmol/Kg per scan) and 8 thalassemia patients who never received Gadobutrol. Moreover, we included 13 healthy subjects who never received Gadobutrol as control group. Iron overload was assessed by the T2* technique. Signal intensity (SI) ratios in all regions were comparable among the three groups (see Table) and were not correlated with the number of Gadobutol administrations. No correlation was detected between SI ratios and T2* values. It is important to underline that thalassemia patients represent an high-risk population for the GBCA accumulation, due to the fact that, in presence of siderosis, ferric ions can compete with Gadolinium ions for the ligand, destabilizing the gadolinium complex. Nevertheless, our study describes the lack of increased SI after repeated administration of Gadobutrol, a nonionic macrocyclic agent. All our patients were chelated when they received the GBCA. Different studies showed the ability of all three iron chelators to chelate other metals. So, a potential role of chelation therapy may be supposed. Table View large Download slide Table View large Download slide  Close modal Disclosures Pepe: Chiesi Farmaceutici and ApoPharma Inc.: Other: Alessia Pepe is the PI of the MIOT project, that receives no profit support from Chiesi Farmaceutici S.p.A. and ApoPharma Inc.",
    "topics": [
        "brain",
        "gadobutrol",
        "thalassemia",
        "magnetic resonance imaging",
        "gadolinium",
        "ions",
        "iron overload",
        "brain mri",
        "chelation therapy",
        "gadolinium-based contrast agents"
    ],
    "author_names": [
        "Antonella Meloni, PhD",
        "Domenico Montanaro",
        "Daniele De Marchi",
        "Maria Chiara Resta",
        "Petra Keilberg",
        "Laura Pistoia, MD",
        "Anna Spasiano",
        "Tommaso Casini",
        "Caterina Cinzia De Bari",
        "Sara De Cori",
        "Vincenzo Positano",
        "Paolo Di Bartolomeo, MD",
        "Alessia Pepe, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Antonella Meloni, PhD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Domenico Montanaro",
            "author_affiliations": [
                "Unit\u00e0 di Neuroradiologia, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniele De Marchi",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Chiara Resta",
            "author_affiliations": [
                "Istituto di Radiologia, Policlinico Universit\u00e0 di Bari, Bari, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Petra Keilberg",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laura Pistoia, MD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Spasiano",
            "author_affiliations": [
                "Unit\u00e0 Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale \"A. Cardarelli\", Napoli, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tommaso Casini",
            "author_affiliations": [
                "Centro Talassemie ed Emoglobinopatie, Ospedale \"Meyer\", Firenze, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Cinzia De Bari",
            "author_affiliations": [
                "Unit\u00e0 Operativa Immunoematologia e Medicina Trasfusionale, Ospedale \"San Donato\", Arezzo, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara De Cori",
            "author_affiliations": [
                "Unit\u00e0 di Neuroradiologia, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Positano",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Di Bartolomeo, MD",
            "author_affiliations": [
                "Department of Hematology, Transfusion Medicine and Biotecnology, \" Spirito Santo \" Civic Hospital, Pescara, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Pepe, MD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-09T21:31:08",
    "is_scraped": "1"
}